Immunoadsorption in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy with Unsatisfactory Response to First-Line Treatment

Norbert Galldiks,Lothar Burghaus,Christian Dohmen,Sven Teschner,Manfred Pollok,Josef Leebmann,Nikolaus Frischmuth,Peter Höllinger,Nahed Nazli,Cordula Fassbender,Reinhard Klingel,Thomas Benzing,Gereon R. Fink,Walter F. Haupt

Immunoadsorption in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy with Unsatisfactory Response to First-Line Treatment

2011

Norbert Galldiks
Lothar Burghaus
Christian Dohmen
Sven Teschner
Manfred Pollok
Josef Leebmann
Nikolaus Frischmuth
Peter Höllinger
Nahed Nazli
Cordula Fassbender
Reinhard Klingel
Thomas Benzing
Gereon R. Fink
Walter F. Haupt

Background/Aims: First-line treatment options for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are corticosteroids, intravenous immunoglobulin, and plasma exchan

Keywords:

Polyradiculoneuropathy
Diabetes mellitus
Immunoadsorption
Anesthesia
Medicine
Physical therapy
Adverse effect
treatment options
Antibody
Internal medicine
first line treatment
Immunology
Gastroenterology
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations